Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EOlife®

K-Number: K221841 · 2023-03-18

ApplicantArcheon
Decision Date2023-03-18
Product CodeBTM
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

EOlife® is the device name listed in this FDA 510(k) record. The listed applicant is Archeon. It received FDA 510(k) clearance on 2023-03-18 under 510(k) number K221841. The device is classified under product code BTM. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EOlife®?

EOlife® is a medical device that received FDA 510(k) clearance on 2023-03-18. The listed applicant is Archeon. The 510(k) number is K221841.

When did EOlife® receive FDA 510(k) clearance?

EOlife® received FDA 510(k) clearance on 2023-03-18, under 510(k) number K221841.

Who is the listed applicant for EOlife®?

The FDA 510(k) record lists Archeon as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EOlife®?

The FDA product code for EOlife® is BTM.

Related Devices (Code: BTM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.